Sign in

Josh Leisring

@joshleisring.bsky.social
249 followers 120 following 100 posts

Nephrologist / Hypertension Specialist in Columbus, Ohio #Nephsky He / him

PostsRepliesMedia
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 08/09/2026
It’s that time of the year If you enjoy and like and use #NephJC content, please consider supporting www.nephjc.com/news/2026/9/...
nephjc.com
NephJC 2026 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
053
Reposted by Josh Leisring
Joel Topf @kidneyboy.bsky.social · 05/05/2026
Have you heard the news? Dapagliflozin is now $8/month at @costplusdrugs.com Wrote my first script this AM From $1935 to $15 for 90 days at 10 mg per day Inflation is everywhere except #Flozins
0145
Reposted by Josh Leisring
Alex Chang, MD @alexchangmd.bsky.social · 22/04/2026
Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/
063
Reposted by Josh Leisring
Nephrology Journal Club @nephjc.bsky.social · 20/04/2026
Do you prescribe hydralazine? Or, do you 🛑 it as soon as you see it? Hydralazine persists despite TID dosing & risks like... vasculitis 🔥 Are you asking Why-dralazine? ✅The blog by @dramiliflores.bsky.social @nephroseeker.medsky.social #NephSky www.nephjc.com/news/hydralazine-anca-vasculitis
nephjc.com
Why-dralazine?! Population risk of drug induced vasculitis — NephJC
This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide i...
397
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 21/04/2026
A. I am not convinced how a 3X effect in crude becomes a 1.2x effect after PS weighting black box B. As we say in the summary, there are no good reasons to use hydralazine anyways. So small risk:zero benefit = infinite risk:benefit ratio. #NephJC
031
Josh Leisring @joshleisring.bsky.social · 17/04/2026
Great case highlighting utility of metanephrines with AVS in a patient with PA and hypercortisolism (MACS). Traditional AVS uses the aldo:cortisol ratio which is confounded if an adenoma co-secretes cortisol. tinyurl.com/yvhwpt75 @bhallaresearch.bsky.social Always check 1mg DST in PA+adenoma!
tinyurl.com
Hypercortisolism: A Prevalent and Complicating Factor in Primary Aldosteronism | Hypertension
031
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 10/04/2026
How should we measure BP for inpatients? Some consensus criteria and actual measurements from Australia
ahajournals.org
021
Reposted by Josh Leisring
Josh Leisring @joshleisring.bsky.social · 01/04/2026
Please consider joining me on Friday, Apr 10 at 3PM EST for this webinar on Simplifying the Approach to Primary Aldosteronism. #nephsky #htn www.labroots.com/webinar/simp...
labroots.com
Simplifying the Approach to Primary Aldosteronism
• Review the pathophysiology of primary aldosteronism (PA). • Demonstrate that PA is common, and can be found in patients across the entire spectrum of hypertension. • Show th
112
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 02/04/2026
As we suspected Thiazide induced hyponatremia is more seen in older women JNO analysis from Sweden jamanetwork.com/journals/jam...
Figure 2.  Cumulative Incidences of Profound Hyponatremia Among Individuals Who Initiated Thiazides and Calcium Channel Blockers During 2 Years of Follow-Up
0127
Reposted by Josh Leisring
Anand Vaidya @anandvaidya17.bsky.social · 02/04/2026
Re-Defining Primary Aldosteronism authors.elsevier.com/a/1mqFw2d9GI... @jaccjournals.bsky.social #JACC
053
Josh Leisring @joshleisring.bsky.social · 01/04/2026
Please consider joining me on Friday, Apr 10 at 3PM EST for this webinar on Simplifying the Approach to Primary Aldosteronism. #nephsky #htn www.labroots.com/webinar/simp...
labroots.com
Simplifying the Approach to Primary Aldosteronism
• Review the pathophysiology of primary aldosteronism (PA). • Demonstrate that PA is common, and can be found in patients across the entire spectrum of hypertension. • Show th
112
Reposted by Josh Leisring
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 28/03/2026
Practical suggestions for the diagnosis and management of hypertension before, during, and after the start of anticancer therapy #ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Onconephrology 🦀 #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/36621810/
062
Josh Leisring @joshleisring.bsky.social · 19/03/2026
Very nice review reiterating that beta-blockers should not be used as a first-line antihypertensive (outside of select cardiac comorbidities). #nephsky #htn www.ahajournals.org/doi/10.1161/...
1102
Reposted by Josh Leisring
Alex Chang, MD @alexchangmd.bsky.social · 02/03/2026
Use of auto BP devices is rec'd by guidelines but many still measure BP manually. In this preprint, we categorize BP device based on terminal digit (manual BP results in even # terminal digits). Manual BP ~6mmHg lower and associated with 1.16x stroke risk vs automated www.medrxiv.org/content/10.6...
063
Reposted by Josh Leisring
John Giacona, PhD, PA-C @giaconajohn.bsky.social · 28/02/2026
Excellent overview in The Washington Post on the systemic impact of sustained hypertension — from LVH to CKD and cognitive decline. Kudos to Drs. @drwanpen.bsky.social , John B, and @jordybc.bsky.social for evidence base insight. 🔗 www.washingtonpost.com/wellness/202... #Hypertension #Cardiology
washingtonpost.com
What high blood pressure does to your body
Hypertension can affect your mind, heart, eyes and more, often without causing any obvious symptoms at all.
086
Reposted by Josh Leisring
Josh Krasnow @jmksnow.bsky.social · 26/02/2026
Think I just had a pt with olmesartan enteropathy Yall seeing this? I’ve mostly moved away to tel, irb but have a fair number of legacy pts #medsky #cardiosky #nephsky
231
Reposted by Josh Leisring
thecurbsiders.bsky.social @thecurbsiders.bsky.social · 26/02/2026
🧠 Dr. Vaidya’s @anandvaidya17.bsky.social practical approach to primary aldo, distilled into one clean, clinic-ready infographic: This is high-yield, no-fluff, practice-changing stuff.
075
Reposted by Josh Leisring
thecurbsiders.bsky.social @thecurbsiders.bsky.social · 23/02/2026
New! 🎙️🩺🎧 #515 Primary Aldosteronism, A Deep Dive: Easy on the Salt! 🧂⬇️ Hypertension is everywhere and primary aldosteronism is a common (and often missed 👀) cause. Join us with @anandvaidya17.bsky.social of Brigham and Women’s Hospital
062
Reposted by Josh Leisring
Anand Vaidya @anandvaidya17.bsky.social · 23/02/2026
www.youtube.com/watch?v=mqpl...
youtube.com
#515 Primary Aldosteronism, A Deep Dive: Easy on the Salt!
YouTube video by The Curbsiders Internal Medicine Podcast
032
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/02/2026
Very practical UK Kidney Association guidelines for management of BP in Dialysis www.kireports.org/article/S246... KI Reports
UKKA BP in dialysis visual abstract
1104
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 13/02/2026
sweet A @asnpublications.bsky.social perspective argues we need a Spironolactone versus nsMRA head:head trial! journals.lww.com/jasn/pages/a... Bring it on! #NephSky #SpiroStans rejoice
figure 1
183
Reposted by Josh Leisring
Jordy Cohen @jordybc.bsky.social · 09/02/2026
Excited to share our research letter published today in JAMA on the new Apple Watch Hypertension Notification Feature! jamanetwork.com/journals/jam... 1/n
jamanetwork.com
Smartwatch and Hypertension Notification
This cross-sectional study assesses the potential impact of a smartwatch hypertension notification feature for US adults who have not been diagnosed with hypertension.
1148
Reposted by Josh Leisring
Daniel Batlle, MD @daniel-batlle.bsky.social · 09/02/2026
Thank you @asnpublications.bsky.social for posting our paper on the transformation of venous to arterial blood gas. To facilitate calculations, I developed an App “Venous to Arterial Blood Gas” available for free (apps.apple.com/us/app/venou...) @nu-nephrology.bsky.social @feinberg.northwestern.edu
apps.apple.com
Venous to Arterial Blood Gas App - App Store
Download Venous to Arterial Blood Gas by Daniel Batlle on the App Store. See screenshots, ratings and reviews, user tips, and more apps like Venous to Arterial…
152
Reposted by Josh Leisring
Alex Chang, MD @alexchangmd.bsky.social · 22/01/2026
As guidelines rec more Aldo/renin testing in htn, wondering whats labs role to ensure/capture details on relevant factors (timing, Na restriction, meds, KP)? Should labs rec pts test in more standardized conditions, log key details or just do it-clinicians duty to sort out? @askrenal.bsky.social
https://www.endocrine.org/clinical-practice-guidelines/primary-aldosteronism-2
142
Reposted by Josh Leisring
Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS @spjuraschek.bsky.social · 21/01/2026
Excited to share our thoughts on the Apple Watch Hypertension alert! @jordybc.bsky.social @deanpicone.bsky.social @alta-schutte.bsky.social Apple Watch for Hypertension Screening | Hypertension www.ahajournals.org/doi/10.1161/...
ahajournals.org
Apple Watch for Hypertension Screening | Hypertension
0105
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 07/01/2026
Cuffless BP review with @farahwehbe92.bsky.social - incoming HT fellow in Ottawa, with tables, and details of technology, devices and ongoing trials pubmed.ncbi.nlm.nih.gov/41460057/ thanks to @profdg.bsky.social for the invite!
pubmed.ncbi.nlm.nih.gov
Cuffless blood pressure in 2025: from promise to practice: a narrative review - PubMed
Cuffless wearables may be used as adjuncts to surface patterns and support engagement; diagnosis and treatment decisions must be confirmed with validated upper-arm measurements. A pragmatic "good-enough" checklist includes stable calibration over weeks, accuracy across dynamic states and subgroups, …
052
Reposted by Josh Leisring
J. Brian Byrd @jbrianbyrd.bsky.social · 22/12/2025
Dan Batlle & I wrote about testing for primary aldosteronism, bringing a critical lens to the usual approach www.ahajournals.org/doi/full/10....
ahajournals.org
American Heart Association Journals
1135
Reposted by Josh Leisring
thecurbsiders.bsky.social @thecurbsiders.bsky.social · 22/12/2025
🚨 Fresh Hypertension Guidelines Alert 🚨 Don’t get caught treating high blood pressure like it’s 2024 👀 
In Episode #509, West Philly doc Dr. Jordy Cohen @jordybc.bsky.social keeps our hypertension management fresh with a clear walk-through of the new HTN guidelines & more! www.thecurbsiders.com
083
Josh Leisring @joshleisring.bsky.social · 16/12/2025
AHA Scientific Statement on Single-Pill Combination Therapy www.ahajournals.org/doi/10.1161/... #Nephsky
000
Reposted by Josh Leisring
Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS @spjuraschek.bsky.social · 12/12/2025
If you are interested in hypertension training and research, check out our hypertension fellowship. research.bidmc.org/medicine-gme...
research.bidmc.org
Clinical Hypertension Fellowship
113
Reposted by Josh Leisring
Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS @spjuraschek.bsky.social · 11/12/2025
Happy to contribute to this important statement @ahascience.bsky.social on cuffless devices led by @jordybc.bsky.social ! Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association | Hypertension ahajournals.org/doi/10.1161/...
196
Josh Leisring @joshleisring.bsky.social · 11/12/2025
"Older and Black participants had higher aldo-to-renin ratio...and women had higher aldo levels than men across the lifespan. With newly expanded indications for PA testing, a greater appreciation of the influence of demographic characteristics will be required." #nephsky tinyurl.com/yc8ryxmu
tinyurl.com
Impact of Age, Sex, and Race on Primary Aldosteronism Test Interpretations | Hypertension
BACKGROUND: New guidelines recommend testing for primary aldosteronism (PA) in all people with hypertension. Interpreting population-based results for PA will require understanding the influence of de...
110
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 09/12/2025
Our take on the baxdrostat PA trial in @asnpublications.bsky.social #KidneyNews www.kidneynews.org/view/journal... with @nephroseeker.medsky.social and @dramiliflores.bsky.social ! Thanks to Sam Kant and @kdjhaveri.bsky.social for the invite!!
VA of SPARK trial
1167
Reposted by Josh Leisring
Nephrology Journal Club @nephjc.bsky.social · 04/12/2025
🆕 #NephJCshort by @brianrifkin.bsky.social RETREAT-FRAIL- pragmatic RCT: is less BP medication worse in octogenarians? www.nephjc.com/news/hyperte...
nephjc.com
NephJC Shorts: Hypertension and The Extreme Elderly — NephJC
The NephJC shorts version of the Hypertension medication step-down in a nursing home population from NEJM
2137
Reposted by Josh Leisring
grahamabra.bsky.social @grahamabra.bsky.social · 02/12/2025
My first month of trying to prescribe fish oil at the dialysis unit has been a total failure Pharmacies arn’t filling scripts and patients can’t find OTC matches to dose prescribed in PISCES Anyone having success on the high seas?
122
Reposted by Josh Leisring
haysamrady @sodatroubles.bsky.social · 20/11/2025
To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension #nephsky #nephrology www.nejm.org/doi/full/10....
nejm.org
To Treat or Not to Treat? Watchful Waiting or Oral Antihypertensives for Asymptomatic Inpatient Hypertension | NEJM
This feature about a man hospitalized for uncomplicated diverticulitis who is found to have high blood pressure offers a case vignette accompanied by two essays, one supporting ...
021
Reposted by Josh Leisring
Vivek Bhalla, MD, FASN, FAHA @bhallaresearch.bsky.social · 05/11/2025
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN. med.stanford.edu/nephrology/e...
med.stanford.edu
Hypertension Fellowship
076
Reposted by Josh Leisring
Michelle Rheault, MD @rheaultm.bsky.social · 05/11/2025
Samir Parikh gives an update on lupus nephritis. #KidneyWk Looking for rapid reduction of proteinuria? Voclosporin is faster, but belimumab showed similar separation from placebo, it just takes longer due to mechanism of action.
274
Reposted by Josh Leisring
NEJM.org @nejm.org · 15/10/2025
BaxHTN phase 3 trial: Aldosterone dysregulation is considered a key driver of hard-to-control hypertension. Research findings on baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in hard-to-control hypertension are summarized in a new Quick Take video. nej.md/3KCsQGJ
A visual representation of the BaxHTN phase 3 trial, which evaluated baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in patients with hard-to-control hypertension.
0125
Josh Leisring @joshleisring.bsky.social · 02/10/2025
Donate and represent! #NephJC
021
Reposted by Josh Leisring
Tim Doulton @kentkidneydoc.bsky.social · 30/09/2025
Our @ukkidney.org guidelines here in BMC Nephrology. 💯% agree that in-unit BP should ONLY be used for determining safety of individual HD sessions and NOT long-term CV risk modification. But changing practice will be a long haul. link.springer.com/epdf/10.1186...
link.springer.com
Management of blood pressure in adults, children and young people on dialysis: UK kidney association clinical practice guideline
142
Reposted by Josh Leisring
John Giacona, PhD, PA-C @giaconajohn.bsky.social · 29/09/2025
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
ahajournals.org
Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention? | Circulation
087
Reposted by Josh Leisring
Cristina Popa @nephroseeker.medsky.social · 28/09/2025
#NephJC is a labor of a passionate volunteer team that believes education should be accessible, no matter where you are from in the world. Even if editorial team donates unlimited hours of sleep, there are still costs to cover 💸 (👇 blog) 😊 Be kind, help us to #NephItForward #Medsky #Nephsky
043
Reposted by Josh Leisring
Vivek Bhalla, MD, FASN, FAHA @bhallaresearch.bsky.social · 25/09/2025
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 . med.stanford.edu/hypertension/e… -Jehan Zahid Bahrainwala HTN Fellowship Program Director
med.stanford.edu
0158
Reposted by Josh Leisring
Nephrology Journal Club @nephjc.bsky.social · 22/09/2025
It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
nephjc.com
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
01613
Reposted by Josh Leisring
Rémi Goupil @goupilremi.bsky.social · 22/09/2025
🚨 Survey Alert! Standardized office BP measurements are recommended everywhere, but still underused. We want to hear from you: what are the barriers to using them as a routine in clinical practice? Click here to read the consent form and take the survey: redcap.link/barriers.to....
023
Reposted by Josh Leisring
Soumya Rangarajan, MD, MPP @soumya-goblue.bsky.social · 20/09/2025
My guess is at least 500 #doctors at my #hospital are on H1B visas including at least a few dozen #hospitalists, and if we lose even a handful to other countries our house of cards #healthcare system will fall apart, let alone all 500+
57537
Reposted by Josh Leisring
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 19/09/2025
Some of my opinions here on @ajkd.bsky.social Blog; ajkdblog.org/2022/01/19/b... The @ahascience.bsky.social also has a scientific statement here from 2023 www.ahajournals.org/doi/full/10.... #NephJC Catch up
ajkdblog.org
Blood Pressure Measurement in Dialysis: There’s No Place Like Home (Part 1)
This is a 2-part blog post by #NephJC cofounder, hypertension guru, and longtime AJKD contributor Swapnil Hiremath. In Part 1, he outlines the quandaries of blood pressure management in hemodialysi…
172
Josh Leisring @joshleisring.bsky.social · 18/09/2025
Reposting this again - very relevant for #NephJC discussion on the new AHA/ACC guidelines.
062
Reposted by Josh Leisring
Nephrology Journal Club @nephjc.bsky.social · 16/09/2025
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky www.nephjc.com/news/2025/9/ahaacc-htnguide
nephjc.com
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
01914